• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK-Mfn2 signaling pathway.撤回说明：LATS2过表达通过抑制AMPK-Mfn2信号通路减轻肝癌HepG2细胞对索拉非尼介导的死亡的治疗抗性。
Cancer Cell Int. 2019 Dec 30;19:359. doi: 10.1186/s12935-019-1084-7. eCollection 2019.
2
LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.LATS2过表达通过抑制AMPK-Mfn2信号通路减弱肝癌HepG2细胞对索拉非尼介导的死亡的治疗抗性。
Cancer Cell Int. 2019 Mar 18;19:60. doi: 10.1186/s12935-019-0778-1. eCollection 2019.
3
Retraction: Mfn2 overexpression attenuates Cardio-Cerebrovascular Ischemia-Reperfusion injury through mitochondrial fusion and activation of the AMPK/Sirt3 signaling.撤回声明：线粒体融合蛋白2（Mfn2）过表达通过线粒体融合及激活AMPK/Sirt3信号通路减轻心脑血管缺血再灌注损伤。
Front Cell Dev Biol. 2022 Aug 4;10:1006496. doi: 10.3389/fcell.2022.1006496. eCollection 2022.
4
Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway.撤稿说明：白细胞介素-2通过促进线粒体分裂和激活JNK/TAZ途径增强索拉非尼诱导的肝癌细胞凋亡。
Cancer Cell Int. 2019 Dec 30;19:358. doi: 10.1186/s12935-019-1083-8. eCollection 2019.
5
LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways.LATS2通过Prx3-Mfn2-线粒体自噬途径促进心肌细胞H9C2凋亡。
J Recept Signal Transduct Res. 2019 Oct-Dec;39(5-6):470-478. doi: 10.1080/10799893.2019.1701031. Epub 2019 Dec 12.
6
Retraction Note: Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.撤稿说明：DNA聚合酶β的A613T和G462T变体过表达削弱食管癌细胞系的化疗敏感性。
Cancer Cell Int. 2019 Apr 8;19:88. doi: 10.1186/s12935-019-0814-1. eCollection 2019.
7
PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK-CREB-Mfn2-mitophagy signaling pathway.PTEN 抑制通过调节 AMPK-CREB-Mfn2-线粒体自噬信号通路减轻冠心病内皮细胞凋亡。
J Cell Physiol. 2020 May;235(5):4878-4889. doi: 10.1002/jcp.29366. Epub 2019 Oct 25.
8
Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways.撤稿说明：厄洛替尼引发的过度线粒体碎片化通过激活mROS-HtrA2/Omi途径促进胰腺癌PANC-1细胞凋亡
Cancer Cell Int. 2019 Nov 12;19:286. doi: 10.1186/s12935-019-1019-3. eCollection 2019.
9
Overexpression of ERβ Participates in the Progression of Liver Cancer via Inhibiting the Notch Signaling Pathway [Retraction].雌激素受体β的过表达通过抑制Notch信号通路参与肝癌进展[撤回]
Onco Targets Ther. 2020 Jul 16;13:6849. doi: 10.2147/OTT.S270080. eCollection 2020.
10
Retraction Note to: Mutation pattern is an influential factor on functional mutation rates in cancer.撤稿说明：突变模式是影响癌症功能突变率的一个因素。
Cancer Cell Int. 2017 Jul 5;17:67. doi: 10.1186/s12935-017-0436-4. eCollection 2017.

引用本文的文献

1
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways.肝癌防治中植物成分的综合述评：靶向分子信号通路的见解。
Med Oncol. 2024 May 4;41(6):134. doi: 10.1007/s12032-024-02333-5.
2
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy.携带EGFR突变的晚期非小细胞肺癌靶向治疗的耐药性：从机制分析到临床策略
J Cancer Res Clin Oncol. 2021 Dec;147(12):3653-3664. doi: 10.1007/s00432-021-03828-8. Epub 2021 Oct 18.
3
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p.人类新基因LNC-HC通过隔离hsa-miR-183-5p抑制肝癌细胞增殖。
Mol Ther Nucleic Acids. 2020 Jun 5;20:468-479. doi: 10.1016/j.omtn.2020.03.008. Epub 2020 Mar 20.

本文引用的文献

1
LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.LATS2过表达通过抑制AMPK-Mfn2信号通路减弱肝癌HepG2细胞对索拉非尼介导的死亡的治疗抗性。
Cancer Cell Int. 2019 Mar 18;19:60. doi: 10.1186/s12935-019-0778-1. eCollection 2019.
2
Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway.TAZ的基因消融通过激活CaMKII/MIEF1信号通路诱导肝癌HepG2细胞凋亡。
Onco Targets Ther. 2019 Mar 1;12:1765-1779. doi: 10.2147/OTT.S196142. eCollection 2019.
3
Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways.丹参酮IIA通过激活JNK-Mff信号通路促进线粒体分裂，从而降低SW837结肠癌细胞的活力。
BMC Cell Biol. 2018 Sep 25;19(1):21. doi: 10.1186/s12860-018-0174-z.

撤回说明：LATS2过表达通过抑制AMPK-Mfn2信号通路减轻肝癌HepG2细胞对索拉非尼介导的死亡的治疗抗性。

Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK-Mfn2 signaling pathway.

作者信息

Song Jie, Zhao Wei, Lu Chang, Shao Xue

机构信息

1Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University, Changchun, 130000 China.

2Department of Pharmacy, The Second Hospital of Jilin University, Changchun, 130000 China.

出版信息

Cancer Cell Int. 2019 Dec 30;19:359. doi: 10.1186/s12935-019-1084-7. eCollection 2019.

DOI:10.1186/s12935-019-1084-7
PMID:31892858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6936120/
Abstract

[This retracts the article DOI: 10.1186/s12935-019-0778-1.].

摘要

[本文撤回文章DOI：10.1186/s12935-019-0778-1。]